Day: 22. November 2017

Kyoto’s CiRA establishs screening system for Alzheimer (AD)-related drugs

The sceening developed by Haruhisa INOUE at Kyoto University’s Center for (CiRA) is based on cerebral cortical neurons derived from Alzheimer patients and uses compound libraries that are known to reduce amyloid β (Aβ). The cerebral cortical neurons used in the screening are obtained from iPS cells derived from AD patients by introducing the neural […]

Scroll to top